therascreen PIK3CA RGQ PCR Kit
FDA-approved real-time PCR PIK3CA companion diagnostic for breast cancer.
- Developer
- QIAGEN
- Intended use
- Other
- Cancer scope
- Breast cancer
- Specimen
- FFPE tumor tissue, Plasma
- Molecular modality
- DNA mutation
- Current version
- therascreen PIK3CA RGQ PCR Kit P190001/S002 current lineage
- Evidence context
- 0 structured studies · 0 indexed performance results · 5 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.